The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans
Abstract
The cytochrome P450 14alpha-demethylase, encoded by the ERG11 (CYP51) gene, is the primary target for the azole class of antifungals. Changes in the azole affinity of this enzyme caused by amino acid substitutions have been reported as a resistance mechanism. Nine Candida albicans strains were used in this study. The ERG11 base sequence of seven isolates, of which only two were azole-sensitive, were determined. The ERG11 base sequences of the other two strains have been published previously. In these seven isolates, 12 different amino acid substitutions were identified, of which six have not been described previously (A149V, D153E, E165Y, S279F, V452A and G4655). In addition, 16 silent mutations were found. Two different biochemical assays, subcellular sterol biosynthesis and CO binding to reduced microsomal fractions, were used to evaluate the sensitivity of the cytochromes for fluconazole and itraconazole. Enzyme preparations from four isolates showed reduced itraconazole susceptibility, whereas more pronounced resistance to fluconazole was observed in five isolates. A three-dimensional model of C. albicans Cyp51p was used to position all 29 reported substitutions, 98 in total identified in 53 sequences. These 29 substitutions were not randomly distributed over the sequence but clustered in three regions from amino acids 105 to 165, from 266 to 287 and from 405 to 488, suggesting the existence of hotspot regions. Of the mutations found in the two N-terminal regions only Y132H was demonstrated to be of importance for azole resistance. In the C-terminal region three mutations are associated with resistance, suggesting that the non-characterized substitutions found in this region should be prioritized for further analysis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“lanosterol 14α-demethylase (Cyp51), an iron-requiring heme protein (31) involved in ergosterol biosynthesis”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [31]
In the citing paper
“In clinical isolates of C. albicans, over 140 distinct Erg11 amino acid substitutions have been reported in the literature, with most clustering into three hot spot regions9,10.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [10]
In the citing paper
“While the potential contribution to triazole resistance of this F126L-encoding mutation in C. albicans has not been delineated, the F126 residue is predicted to reside near the ligand access channel and modifications to this residue may interfere with the binding of sterol-demethylase inhibitors (20).”
From Delineation of the Direct Contribution of Candida auris ERG11 Mutations to Clinical Triazole Resistance (2021) · cites this paper as [20]
In the citing paper
“However, a single mutation resulting in the F126L substitution was found in a highly fluconazole-resistant C. albicans clinical isolate in conjunction with mutations encoding the E266D, S405F, and V437I substitutions (20).”
From Delineation of the Direct Contribution of Candida auris ERG11 Mutations to Clinical Triazole Resistance (2021) · cites this paper as [20]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 2×
“The protein content of the S )!!! supernatant fraction was 2702 Downloaded from www.microbiologyresearch.org by IP: 54.70.40.11 On: Wed, 24 Oct 2018 18:37:37 measured according to the Bio-Rad method using bovine serum albumin as a standard (Bradford, 1976).”
MethodInfluentialClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · cited 2×
“These studies resulted in a series of reviews dedicated to this subject (Bodey, 1997; De Muri & Hostetter, 1995; Denning et al., 1997; Dupont, 1995; Frosco & Barrett, 1998; Hartman & Sanglard, 1997; Johnson & Warnock, 1995; Joseph-Horn & Hollomon, 1997; Marichal & Vanden Bossche, 1995; Odds, 1998; Rex et al., 1995; Sa…”
BackgroundResistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 877 · cited 2×
“These studies resulted in a series of reviews dedicated to this subject (Bodey, 1997; De Muri & Hostetter, 1995; Denning et al., 1997; Dupont, 1995; Frosco & Barrett, 1998; Hartman & Sanglard, 1997; Johnson & Warnock, 1995; Joseph-Horn & Hollomon, 1997; Marichal & Vanden Bossche, 1995; Odds, 1998; Rex et al., 1995; Sa…”
BackgroundSanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815 · cited 6×
“CaMDR1, previously described as BENr) with a much narrower substrate spectrum (Sanglard et al., 1995).”
BackgroundInfluentialSanglard, D., Ischer, F., Koymans, L., & Bille, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465 · cited 13×
“…[suggested by biochemical data (Vanden Bossche et al., 1990) or by sequence analysis], such as Y132H (tyrosine 132 is replaced by a histidine ; Sanglard et al., 1998b), T315A (threonine 315 replaced by alanine; Lamb et al., 1997) or R476K (arginine 476 replaced by lysine; White, 1997), have…”
BackgroundMethodResultInfluentialSelf-citationKelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351 · cited 2×
“albicans isolate (Kelly et al., 1997) as well as in Saccharomyces cerevisiae (Bard et al.”
BackgroundWhite, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1488 · Cited by 292 · cited 3×
“…or by sequence analysis], such as Y132H (tyrosine 132 is replaced by a histidine ; Sanglard et al., 1998b), T315A (threonine 315 replaced by alanine; Lamb et al., 1997) or R476K (arginine 476 replaced by lysine; White, 1997), have been shown to decrease the affinity of the target for an azole.”
BackgroundAntifungal drug resistance in pathogenic fungi.
BOSSCHE, H. V., Dromer, F., Improvisi, I., Lozano‐Chiu, M., Rex, J. H., & Sanglard, D. (1998) · PubMed · Cited by 290
In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis
Van den Bossche, H., Willemsens, G., Cools, W., Cornelissen, F., Lauwers, W. F., & van Cutsem, J. M. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.6.922 · Cited by 276 · cited 1×
“Two of them, ATCC 28516 and ATCC 44858, were extensively used in previous biochemical studies (Vanden Bossche et al., 1980) and were azolesensitive.”
MethodMolecular mechanisms of drug resistance in fungi
Vanden Bossche, H., Marichal, P., & Odds, F. C. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90618-1 · Cited by 254 · cited 15×
“Two of them, ATCC 28516 and ATCC 44858, were extensively used in previous biochemical studies (Vanden Bossche et al., 1980) and were azolesensitive.”
InfluentialSelf-citation
Research works printed but not linked: 2
- 1997, Rev Iberoam Micol, 14, 44
- 1997, Mycoses, 41, 32
Cited by
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900
“Several studies have attributed C. krusei’s innate azole resistance to efflux pump activity, namely through the ATP-binding cassette transporter Abc1p, and reduced drug accumulation (Marichal et al., 1995; Katiyar and Edlind, 2001; Lamping et al., 2009) in combination with reduced azole affinity for Erg11p (Marichal e…”
BackgroundInfluentialAntifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Resistance to Antifungal Agents: Mechanisms and Clinical Impact
Kanafani, Z. A., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/524071 · Cited by 619
“The development of fluconazole resistance among Candida albicans and C. neoformans strains illustrates this type of resistance [25, 26].”
BackgroundEfflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583
Metadata
- Authors
- Marichal, P., Koymans, L., Willemsens, S., Bellens, D., Verhasselt, P., Luyten, W., Borgers, M., Ramaekers, F. C. S., Odds, F. C., & Vanden Bossche, H.
- Affiliations
- Janssen (Belgium) (BE)
- Maastricht University (NL)
- Department of Anti-infectives Research1, Center for Molecular Design2, Department of Biotechnology3 and Department of Functional Genomics4, Janssen Research Foundation, Turnhoutseweg 30, B2340 Beerse, Belgium
- Corresponding author
- Marichal, Patrick
- Venue
- Microbiology
- Publisher
- Microbiology Society
- Published
- 1999-10-01
- Volume
- 145
- Issue
- 10
- Pages
- 2701-2713
- ISSN
- 1350-0872 (ISSN-L)
- 1465-2080
- OpenAlex
- W1905535572
- Cited by
- 382
- References
- 56
- Citations by year
- 2026: 16 · 2025: 13 · 2024: 13 · 2023: 14 · 2022: 11 · 2021: 19 · 2020: 13 · 2019: 14 · 2018: 5 · 2017: 19 · 2016: 17 · 2015: 13 · 2014: 23 · 2013: 14 · 2012: 14
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida albicans, azole resistance, ERG11, CYP51, fluconazole, itraconazole, amino acid substitutions, synonymous mutations, sterol biosynthesis, carbon monoxide binding, protein 3D structure, hot spots, antifungal resistance
- MeSH terms
- Amino Acid Sequence, Antifungal Agents, Candida albicans, Chromosome Mapping, Cytochrome P-450 Enzyme System, Drug Resistance, Microbial, Microbial Sensitivity Tests, Models, Molecular, Molecular Sequence Data, Mutation, Oxidoreductases, Protein Conformation, Fluconazole, Sequence Alignment, Sequence Analysis, DNA, Protein Structure, Secondary, Itraconazole, Drug Resistance, Multiple, Amino Acid Substitution, Sterol 14-Demethylase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. https://app.cochat.ai/papers/10.1099/00221287-145-10-2701
- The paper
- Marichal, P., Koymans, L., Willemsens, S., Bellens, D., Verhasselt, P., Luyten, W., Borgers, M., Ramaekers, F. C. S., Odds, F. C., & Vanden Bossche, H. (1999). Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology. https://doi.org/10.1099/00221287-145-10-2701
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.